Digital Health Market is expected to reach valuation of US$ 2585.98 billion by 2032 | FMI

 The Global Digital Health Market is expected to reach a valuation of US$ 2585.98 Bn by 2032, with sales growing at an astounding CAGR of 27.7% from 2022 to 2032. Owing to the rising awareness of digital health benefits, the market for the same is likely to expand at a rapid rate and reach an estimated US$ 224.24 Bn by the end of 2022.



Get Complete Access: https://www.futuremarketinsights.com/reports/global-digital-health-market

The deep penetration of electronic gadgets and devices and advancing technology coupled with the rising acceptance of telemedicine and telehealth services will fuel the growth of the digital health market during the forecast period.

With the rapid digitalization of the healthcare sector, the prospects for the digital health market are also set to rise. Increasing usage of advanced technological tools like Big Data and others bodes well for the target market. Telemedicine and telehealth services are also on the rise and are increasingly adopted by both the medical community and public and private entities. This will likely have a positive impact on the digital health market.

Moreover, the increasing prevalence of chronic diseases like cancer, cardiovascular diseases, diabetes, Alzheimer’s, and other medical conditions that require long-term care and constant patient monitoring contribute to the rising demand for digital health services. In addition, electronic gadgets and smart devices such as smartphones are increasingly used as health and fitness trackers which further aids the growth of the digital health market during the forecast period.

“Improving healthcare IT infrastructure coupled with access to virtual care will stimulate the global growth of the digital health market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • The rising prevalence of medical conditions requiring long-term care and monitoring facilitates market growth of the digital health industry.
  • Concerns regarding patients’ data security stymies market growth during the assessment period.
  • By deployment type, the cloud-based segment will likely reach an estimated US$ 519,151.4 Mn by 2032.
  • On the basis of solution, the software segment is predicted to hold about 45.6% of the digital health market revenue.
  • North America is expected to dominate the global digital health market space with a 45.9% share of the total revenue.
  • The digital health market in South Asia & Pacific is anticipated to reach US$ 275,462.9 Mn by 2032.

Competitive Landscape 

AT&T Inc., Apple Inc., AirStrip Technologies LP, Alcatel-Lucent Corporation, Cerner Corporation, Symantec Corporation, Aruba Networks, Inc., Cisco Systems, Inc., Qualcomm, Inc., Siemens Healthcare, and Philips Healthcare among others are some of the major players in the digital health market profiled in the full version of the report.

Leading market players are focusing on launching state-of-the-art and affordable solutions to retain a competitive edge. These firms also adopt tactics like strategic alliances, partnerships, collaborations, acquisitions, and joint ventures to increase their market share. 

Key Segments

By Solution:

  • Software
    • Healthcare Payers Software
      • Healthcare Claims Management Software
      • Healthcare CRM Software
      • Others
      • Payer Care Management Software
    • Healthcare Providers Software
      • EHR / EMR Software
      • E-Prescribing Software
      • Healthcare Asset Management Software
      • Others
      • Population Health Management Software
  • Services
    • Managed Services
    • Professional Services
      • Healthcare Consulting Services
      • Integration & Implementation Services
      • Support & Maintenance Services

By Deployment:

  • Cloud-based
  • On-Premises

By End User:

  • Diagnostics Centers
  • Healthcare Payers
  • Healthcare Research Centers
  • Hospitals & Clinics
  • Nursing Care Centers
  • Others

Comments

Post a Comment

Popular posts from this blog

Monoclonal Antibodies Market to touch US$ 647.01 Billion by 2032; applications abound in Oncology | FMI Report

Image
  Monoclonal Antibodies Market is projected to increase at a CAGR of 12% during the forecast period between 2022 and 2032, reaching a total of US$ 647.01 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6.1%. Human mAbs offer efficient modulation in effector functions and are less immunogenic as compared to chimeric or humanized mAbs. Such antibodies can be produced through the use of phage display and hybridoma technologies in transgenic mice. As a result, with recent technological progress in genetic engineering, the production of fully human mAbs is anticipated to gain traction in the near future.  Get Full Access @ https://www.futuremarketinsights.com/reports/monoclonal-antibodies-market North America recorded the largest market share of 46.2% in 2021 due to the presence of a highly developed healthcare infrastructure, high patient awareness, and growth in cancer research pr
Read more

Hospital Consumables Market is expected to reach valuation of US$ 853.2 Billion | FMI

  According to Future Market Insights' newly released Hospital Consumables market analysis report, global Hospital Consumables market sales in 2021 are expected to be US$ 346 billion. The estimated market growth of 12.5% between 2022 and 2032 is expected to be much greater than the previous trend. The consumables market is estimated to have a total revenue opportunity of US$ 853.2 billion. The increase in chronic diseases, medical operations, and the expanding older population are driving market expansion. To learn more about this report @ https://www.futuremarketinsights.com/reports/hospital-consumables-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Hospital Consumables market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Hospita
Read more

Companion Diagnostics Market Recent Trends, Dynamic Innovation in Technology & Insights 2032

Image
  The global Companion Diagnostics Market is expected to generate approximately US$ 5152.064939 million by 2032, up from US$ 2452.653722 million in 2022, at a CAGR of 7.1% during the forecast period. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Companion Diagnostics market. To read more about this report, visit @ https://www.futuremarketinsights.com/reports/companion-diagnostics-market FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Companion Diagnostics market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcare sector has been expanding remarkably, followi
Read more